Elbl C, Terracciano L, Stallmach T K, Reinhart W H, Jeker R
Department Innere Medizin, Kantonsspital Graubünden, Chur.
Praxis (Bern 1994). 2012 Feb 1;101(3):195-8. doi: 10.1024/1661-8157/a000829.
A woman, who consumed the recommended daily doses of Relaxane® and Hova® over several months was found to have elevated liver enzymes. A liver biopsy showed histologic changes consistent with primary biliary cirrhosis. After stopping treatment with Relaxane® and Hova® we observed a decline of the increased liver enzymes to normal levels two months later. A second biopsy of the liver three months later showed a clear decline of the initial histologic changes.
一名女性在数月内服用了推荐剂量的Relaxane®和Hova®,结果发现其肝酶升高。肝脏活检显示组织学变化与原发性胆汁性肝硬化相符。在停止使用Relaxane®和Hova®治疗后,我们观察到两个月后升高的肝酶降至正常水平。三个月后对肝脏进行的第二次活检显示最初的组织学变化明显减轻。